• Lupus doubles the risk on cervical neoplasia

    The risk on pre-malignant cervical changes is doubled in women with Systemic Lupus Erythematosus (SLE) compared to the general female population. The highest risks are found in women with SLE who are treated with immunosuppressant drugs. These findings stress the importance for women with SLE to attend cervical screening.

  • Can Biomarkers already guide treatment decisions?

    A post-hoc analysis of a trial in RA patients shows that biomarkers may help to identify patients at risk for progression and thus enable individualised treatment decisions.

  • Patient selection essential for success of viscosupplementation

    Being overweight and radiologic severity of knee osteoarthritis were associated with a lack of response to viscosupplementation in a post hoc analysis of a multicenter, double blind trial.

  • 84 |
  • 85 |
  • 86 |
  • 87 |
  • 88 |
  • 89 |